Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Klinik Nederby ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   18.7% 17.6% 19.8% 16.7% 14.1% 13.9% 20.6% 20.4%   Credit score (0-100)   8 9 5 9 15 16 5 5   Credit rating   B B B BB BB BB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   110 173 170 150 107 91.3 0.0 0.0   EBITDA   50.9 74.8 90.2 46.8 4.7 -4.4 0.0 0.0   EBIT   27.1 42.1 57.4 14.1 -17.3 -4.4 0.0 0.0   Pre-tax profit (PTP)   26.5 40.9 56.7 14.1 -17.1 -3.1 0.0 0.0   Net earnings   20.2 28.9 41.9 9.5 -13.4 -2.5 0.0 0.0   Pre-tax profit without non-rec. items   26.5 40.9 56.7 14.1 -17.1 -3.1 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   120 87.5 54.7 22.0 0.0 0.0 0.0 0.0   Shareholders equity total   78.6 52.2 38.8 48.3 34.9 32.4 -7.6 -7.6   Interest-bearing liabilities   37.2 5.3 9.4 11.0 14.8 19.2 7.6 7.6   Balance sheet total (assets)   145 151 104 89.4 79.5 73.6 0.0 0.0   Net Debt   21.0 -50.1 -24.2 -27.9 -23.6 -5.3 7.6 7.6     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   110 173 170 150 107 91.3 0.0 0.0   Gross profit growth   20.2% 56.9% -1.8% -11.5% -28.9% -14.5% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   145 151 104 89 79 74 0 0   Balance sheet change%   49.0% 4.5% -31.2% -14.1% -11.1% -7.4% -100.0% 0.0%   Added value   50.9 74.8 90.2 46.8 15.5 -4.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   25 -66 -66 -66 -44 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 -1.0 -2.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   24.6% 24.4% 33.9% 9.4% -16.2% -4.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   22.4% 28.6% 45.2% 15.2% -19.4% -2.9% 0.0% 0.0%   ROI %   27.3% 47.5% 107.3% 27.4% -30.0% -4.4% 0.0% 0.0%   ROE %   29.5% 44.2% 92.1% 21.9% -32.2% -7.4% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   54.3% 34.5% 37.3% 54.0% 44.0% 44.1% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   41.2% -67.0% -26.8% -59.5% -504.3% 120.9% 0.0% 0.0%   Gearing %   47.4% 10.1% 24.3% 22.8% 42.4% 59.3% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   2.1% 6.5% 13.8% 6.7% 5.5% 5.4% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   0.4 0.7 0.8 1.6 1.8 1.8 0.0 0.0   Current Ratio   0.4 0.7 0.8 1.6 1.8 1.8 0.0 0.0   Cash and cash equivalent   16.2 55.4 33.6 38.9 38.4 24.6 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -38.4 -33.5 -15.9 26.4 34.9 32.4 -3.8 -3.8   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   51 75 90 47 15 -4 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   51 75 90 47 5 -4 0 0   EBIT / employee   27 42 57 14 -17 -4 0 0   Net earnings / employee   20 29 42 10 -13 -2 0 0